Roberta Cirsmaru/LinkedIn
Jul 8, 2026, 05:53
Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn:
”Delighted to have served on the PhD defense committee of Roberta Cirsmaru, supervised by my friend Professor Follenzi.
Her thesis presented outstanding and innovative work in regenerative medicine, exploring the potential of ex vivo gene-modified BOECs for the treatment of hemophilia A.
Congratulations to Roberta on this excellent scientific achievement.
It was a pleasure to take part in such stimulating discussions on a field that continues to push the boundaries of translational medicine.”
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia